Risk factors and outcome of COVID-19 in patients with hematological malignanciesJosé Luís Piñana, Anna Sureda, Irene Gómez-Catalán et al.|Experimental Hematology and Oncology|2020Cited by 159
<scp>SARS‐CoV</scp>‐2‐reactive antibody detection after <scp>SARS‐CoV</scp>‐2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy GroupJosé Luís Piñana, Anna Sureda, Lucía López‐Corral et al.|American Journal of Hematology|2021Cited by 64
SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disordersJosé Luís Piñana, David Navarro, Lucía López‐Corral et al.|Journal of Hematology & Oncology|2022Cited by 39